Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-neuron neurodegeneration as a degenerative model for Parkinson’s disease
Sandro Huenchuguala, Juan Segura‐Aguilar
Neural Regeneration Research (2023) Vol. 19, Iss. 3, pp. 529-535
Open Access | Times Cited: 16

Showing 16 citing articles:

Mitochondrial dysfunction in chronic neuroinflammatory diseases (Review)
Pei Qin, Ye Sun, Liya Li
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 5
Open Access | Times Cited: 9
The neuroprotective effects of ferulic acid in toxin-induced models of Parkinson's disease: A review
Samira Hassani, Abolghasem Esmaeili
Ageing Research Reviews (2024) Vol. 97, pp. 102299-102299
Closed Access | Times Cited: 7
Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson’s Disease According to the Single-Neuron Degeneration Model
Sandro Huenchuguala, Juan Segura‐Aguilar
Biomolecules (2024) Vol. 14, Iss. 6, pp. 673-673
Open Access | Times Cited: 6
Highly selective colorimetric determination of glutathione based on sandwich-structured nanoenzymes composed of gold nanoparticle–coated molecular imprinted metal–organic frameworks
Xiaolin Lü, Liqiu Yan, Xiaoxue Zhou, et al.
Microchimica Acta (2024) Vol. 191, Iss. 3
Closed Access | Times Cited: 5
To what extent may aminochrome increase the vulnerability of dopaminergic neurons in the context of Parkinson's disease
Abdeslam Chagraoui, Youssef Anouar, Philippe De Deurwaerdère, et al.
The International Journal of Biochemistry & Cell Biology (2024) Vol. 168, pp. 106528-106528
Closed Access | Times Cited: 4
Advances in animal models of Parkinson's disease
He Sui, Qin Ru, Lin Chen, et al.
Brain Research Bulletin (2024) Vol. 215, pp. 111024-111024
Open Access | Times Cited: 4
Recalibrating the Why and Whom of Animal Models in Parkinson Disease: A Clinician’s Perspective
Andrea Sturchio, Emily M. Rocha, Marcelo A. Kauffman, et al.
Brain Sciences (2024) Vol. 14, Iss. 2, pp. 151-151
Open Access | Times Cited: 3
Real-Time Monitoring of Tyrosine Hydroxylase Activity with a Ratiometric Fluorescent Probe
Jiayi Yao, Lü Li, Ji‐Xuan Xu, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 18, pp. 7082-7090
Closed Access | Times Cited: 3
Experimental Parkinson models and green chemistry approach
Özge AKYAZI, Dılara Korkmaz, Şule Çoşkun Cevher
Behavioural Brain Research (2024) Vol. 471, pp. 115092-115092
Closed Access | Times Cited: 2
Location and interaction of idebenone and mitoquinone in a membrane similar to the inner mitochondrial membrane. Comparison with ubiquinone 10
José Villalaı́n
Free Radical Biology and Medicine (2024) Vol. 222, pp. 211-222
Open Access | Times Cited: 1
Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson’s Disease
Sandro Huenchuguala, Juan Segura‐Aguilar
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1125-1125
Open Access | Times Cited: 1
L-Theanine Effectively Protects Against Copper-Facilitated Dopamine Oxidation: Implication for Relieving Dopamine Overflow-Associated Neurotoxicities
Fu‐Ming Wang, Xiaoyu Huang, Wenping Wang, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 1
Oxyphylla A exerts antiparkinsonian effects by ameliorating 6-OHDA-induced mitochondrial dysfunction and dyskinesia in vitro and in vivo
Min Shao, Chen Zhao, Zhijian Pan, et al.
Chemico-Biological Interactions (2024) Vol. 403, pp. 111224-111224
Closed Access
Coumarin-chalcone derivatives as dual NLRP1 and NLRP3 inflammasome inhibitors targeting oxidative stress and inflammation in neurotoxin-induced HMC3 and BE(2)-M17 cell models of Parkinson's disease
Te‐Hsien Lin, Ya‐Jen Chiu, Chih‐Hsin Lin, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
Glutathione S-transferase: A keystone in Parkinson's disease pathogenesis and therapy
Pratyush Padhan, Simran Simran, Neeraj Kumar, et al.
Molecular and Cellular Neuroscience (2024), pp. 103981-103981
Closed Access
Toward understanding the role of genomic repeat elements in neurodegenerative diseases
Zhengyu An, Aidi Jiang, Jingqi Chen
Neural Regeneration Research (2024) Vol. 20, Iss. 3, pp. 646-659
Open Access
Page 1

Scroll to top